In Vitro Recapitulation of Developmental Transitions in Human Neural Stem Cells

Total Page:16

File Type:pdf, Size:1020Kb

In Vitro Recapitulation of Developmental Transitions in Human Neural Stem Cells Page 1 of 185 Ostermann, Ladewig et al., 1 Running title: NS cells from NES cells In vitro recapitulation of developmental transitions in human neural stem cells Laura Ostermann1*, Julia Ladewig1,5,6,7*, Franz-Josef Müller2, Jaideep Kesevan1, Jignesh Tailor3, Austin Smith3,4, Oliver Brüstle1#, Philipp Koch1,5,6,7# (1) Institute of Reconstructive Neurobiology, University of Bonn School of Medicine & University Hospital Bonn, Bonn, Germany (2) Department of Psychiatry and Psychotherapy, Centre for Integrative Psychiatry, Kiel, Germany (3) Wellcome Trust - Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom (4) Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom (5) Central Institute of Mental Health, University of Heidelberg, Medical Faculty Mannheim, Mannheim, Germany (6) HITBR Hector Institute for Translational Brain Research gGmbH, Heidelberg, Germany (7) German Cancer Research Center (DKFZ), Heidelberg, Germany * these authors contributed equally to the study # To whom correspondence should be addressed: Prof. Dr. Philipp Koch (M.D.) Hector Institute for Translational Brain Research Central Institute of Mental Health University of Heidelberg / Medical Faculty Mannheim Square J5 68159 Mannheim Phone: +49(0)621 17036711 Email: [email protected] Prof. Dr. Oliver Brüstle (M.D.) Institute of Reconstructive Neurobiology Life&Brain Center University of Bonn Medical Faculty Sigmund-Freud-Str. 25 53127 Bonn Phone: +49 (0)228 6885 500 Fax.: +49 (0)228 6885 501 Email: [email protected] Author Contributions Laura Ostermann, Franz-Josef Müller, Jaideep Kesevan: collection and assembly of data, data analysis and interpretation, manuscript writing. Jignesh Tailor, Austin Smith: provision of study material, data analysis and interpretation. Oliver Brüstle: financial support, data analysis and interpretation, manuscript writing. Julia Ladewig and Philipp Koch: Conception and design, collection and assembly of data, data analysis and interpretation, manuscript writing. All authors approved the manuscript. Key words: stem cell biology, neural stem cells, neuroepithelial stem cells, radial glia stem cells, regional identity Page 2 of 185 Ostermann, Ladewig et al., 2 ABSTRACT During nervous system development, early neuroepithelial stem (NES) cells with a highly polarized morphology and responsiveness to regionalizing morphogens give rise to radial glia (RG) cells, which generate region-specific neurons. Recently, stable neural cell populations reminiscent of NES cells have been obtained from pluripotent stem cells and the fetal human hindbrain. Here we explore whether these cell populations, similar to their in vivo counterparts, can give rise to neural stem (NS) cells with radial glia-like properties and whether region-specific NS cells can be generated from NES cells with different regional identity. In vivo RG cells are thought to form from NES cells with the onset of neurogenesis. We therefore cultured NES cells temporarily in differentiating conditions. Upon re-initiation of growth factor treatment, cells were found to enter a developmental stage reflecting major characteristics of radial glia-like NS cells. These NES cell-derived NS cells exhibited a very similar morphology and marker expression as compared to primary NS cells generated from human fetal tissue, indicating that conversion of NES cells into NS cells recapitulates the developmental progression of early NES cells into RG cells observed in vivo. Importantly, NS cells generated form NES cells with different regional identities exhibited stable region-specific transcription factor expression and generated neurons appropriate for their positional identity. Page 3 of 185 Ostermann, Ladewig et al., 3 INTRODUCTION Neural stem cells (NSC) represent a self-renewing, multipotent somatic stem cell population of the central nervous system (CNS). They serve as source for the different cell types of the brain including neurons, astrocytes and oligodendrocytes 1, 2. During early embryonic development the neuroectoderm is generated from the ectodermal layer and folds into the neural tube, which initially consists of a single layer of rapidly and symmetrically dividing neuroepithelial stem cells (NES cells). In this context, the term ‘neuroepithelial’ accounts for the fact, that these cells exhibit multiple epithelial characteristics. For instance, they are highly polarized spanning from the apical to the basal side of the neural tube. As other epithelial tissues, they form adherens and tight junctions at their apical pole 3. As from the initial pool of neuroepithelial cells all the diverse regional brain identities along the anterior- posterior and dorso-ventral axis are generated, neuroepithelial cells are highly responsive to extrinsic patterning signals and morphogens 4, 5. At the onset of neurogenesis and following extensive proliferation, NES cells transform into radial glia (RG) cells, the major stem cell population of the embryonic and fetal brain 2, 3, 6. RG cells maintain several aspects of NES cells such as their self-renewing capacity, their multipotentiality as well as their apical-basal polarity. They exhibit long radial processes, which span through the developing brain while staying attached to the pial surface and the luminal side 7, 8. During neurogenesis, these radial processes serve as guiding tracks for radially migrating neurons 3, 8. The term radial ‘glia’ refers to the fact that RG cells share many immunohistochemical characteristics with glial cells such as the expression of the astrocyte specific glutamate transporter (GLAST). During the transition of NES cells into RG cells, RG cells get progressively specified and their responsiveness to regionalizing morphogens diminishes. As a consequence, RG cells are regionally determined and consistently give rise to neuronal progeny of their region of origin 2, 9-11. In the last decades, various strategies for the isolation and in vitro expansion of different neural stem and progenitor populations have been described using free-floating aggregates Page 4 of 185 Ostermann, Ladewig et al., 4 called neurospheres or monolayer culture systems 12-15. Similar to their in vivo counterpart, in vitro cultured neural stem and progenitor cells are defined by their ability to self-renew and their multipotent differentiation capacity. In vitro neural stem cells, however, rely on the addition of growth factors such as fibroblast growth factor (FGF) or epithelial growth factor (EGF) and the extent to which in vitro propagated NSCs correlate to NSCs found in vivo remains controversial 12. In the human system, two distinct expandable and well-characterized neural stem/progenitor cell populations have recently been established. Human NS cells isolated from embryos beyond Carnegie stage 17 share many aspects of radial glia such as a bipolar morphology or expression of typical radial glia-associated markers including brain lipid binding protein (BLBP), GLAST or 3CB2 16. Using pluripotent stem cells as a starting population, we established a population of long-term self-renewing neuroepithelial stem cells (lt-NES cells; 14, 17). These cells are characterized by their continued ability to form rosette-like structures in vitro and, in the presence of morphogens, can be guided towards distinct regional identities 14. Interestingly, lt-NES cells could also be generated from primary human brain tissue when applying early fetal brain sources before Carnegie stage 17, indicating that lt-NES cells do have an in vivo correlate 18. Thus, isolation and propagation of the two major types of neural stem/progenitor cells, NES- and RG-like NS cells, has been established from primary human brain tissue. How these two populations hierarchically correlate in development and whether lt-NES cells can be converted into NS cells in vitro has, however, not been determined. Here we explored the potential of pluripotent and primary NES cells to give rise to radial glia- like NS cells in vitro. Using partially differentiating conditions to induce neurogenesis and subsequent re-initiation of proliferation with growth factors we were able to establish a multipotent cell population, which exhibits features of RG cells and shows high similarity to primary fetal brain-derived RG-like NS cells. These NES cell-derived NS cells could be expanded for multiple passages and expressed classic radial glia markers, while NES cell markers were down-regulated. Importantly, NS cells generated from forebrain or spinal cord- Page 5 of 185 Ostermann, Ladewig et al., 5 patterned NES cells retain their regional phenotype during multiple passages of in vitro proliferation and upon differentiation. Page 6 of 185 Ostermann, Ladewig et al., 6 MATERIAL AND METHODS Cell culture Lt-NES generated from human embryonic stem cells (hESCs) and primary brain tissue- derived NES cells were maintained in neural stem cell medium containing DMEM/F12, N2 supplement (1:100; both Life Technologies), 1,6 g/L glucose, 10 ng/mL FGF2 (R&D Systems), 10 ng/mL EGF (R&D Systems), 1:1000 B27 and penicillin-streptomycin (1:100, Invitrogen) on poly-L-ornithine /laminin (both Sigma Aldrich) precoated plastic dishes. For the derivation of NS cells, NES cells were induced to differentiate by growth factor withdrawal on Geltrex (Life Technologies) coated dishes in neural differentiation medium containing DMEM/12 (N2 supplement; 1:50) and Neurobasal (B27 supplement; 1:100) mixed at a 1:1 ratio. Medium was changed every other day. After 4
Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0264.634 A1 Amersdorfer Et Al
    US 20120264.634A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0264.634 A1 Amersdorfer et al. (43) Pub. Date: Oct. 18, 2012 (54) MARKER SEQUENCES FOR PANCREATIC Publication Classification CANCER DISEASES, PANCREATIC (51) Int. Cl. CARCINOMIA AND USE THEREOF C40B 30/04 (2006.01) GOIN 2L/64 (2006.01) (75) Inventors: Peter Amersdorfer, Graz (AT); GOIN 27/72 (2006.01) Annabel Höpfner, Dortmund (DE); C07K I4/435 (2006.01) Angelika Lueking, Bochum (DE) C40B 40/06 (2006.01) C40B 40/10 (2006.01) CI2N 5/09 (2010.01) (73) Assignee: PROTAGEN Aktiengesellschaft, C7H 2L/04 (2006.01) Dortmund (DE) GOIN 33/574 (2006.01) GOIN 27/62 (2006.01) (21) Appl. No.: 13/498,964 (52) U.S. Cl. ........... 506/9:436/501; 435/6.14; 435/7.92; 506/16:506/18: 435/2:536/23.1; 530/350 (22) PCT Filed: Sep. 29, 2010 (57) ABSTRACT The present invention relates to novel marker sequences for (86). PCT No.: PCT/EP2010/064510 pancreatic cancer diseases, pancreatic carcinoma and the diagnostic use thereof together with a method for Screening of S371 (c)(1), potential active Substances for pancreatic cancer diseases, (2), (4) Date: Jun. 22, 2012 pancreatic carcinoma by means of these marker sequences. Furthermore, the invention relates to a diagnostic device con (30) Foreign Application Priority Data taining Such marker sequences for pancreatic cancer diseases, pancreatic carcinoma, in particular a protein biochip and the Sep. 29, 2009 (EP) .................................. O9171690.2 use thereof. Patent Application Publication Oct. 18, 2012 US 2012/0264.634 A1 US 2012/0264.634 A1 Oct.
    [Show full text]
  • Análise Correlacional Entre a Expressão Dos Fatores De Splicing E a Ocorrência De Splicing Alternativo Em Tecidos Humanos E De Camundongos
    ANÁLISE CORRELACIONAL ENTRE A EXPRESSÃO DOS FATORES DE SPLICING E A OCORRÊNCIA DE SPLICING ALTERNATIVO EM TECIDOS HUMANOS E DE CAMUNDONGOS JULIO CÉSAR NUNES Dissertação apresentada à Fundação Antônio Prudente para a obtenção do título de Mestre em Ciências Área de Concentração: Oncologia Orientador: Dr. Sandro José de Souza São Paulo 2008 Livros Grátis http://www.livrosgratis.com.br Milhares de livros grátis para download. FICHA CATALOGRÁFICA Preparada pela Biblioteca da Fundação Antônio Prudente Nunes, Julio César Análise correlacional entre a expressão dos fatores de splicing e a ocorrência de splicing alternativo em tecidos humanos e de camundongos / Julio César Nunes – São Paulo, 2008. 79p. Dissertação (Mestrado) - Fundação Antônio Prudente. Curso de Pós-Graduação em Ciências - Área de concentração: Oncologia. Orientador: Sandro José Souza Descritores: 1. SPLICING ALTERNATIVO 2. BIOLOGIA MOLECULAR COMPUTACIONAL 3. CÂNCER 4. GENOMICA. AGRADECIMENTOS Agradeço à FAPESP e CAPES pela bolsa de Mestrado. Ao Sandro José de Souza agradeço toda orientação e conhecimento oferecido. Meus especiais agradecimentos ao Pedro Alexandre Favoretto Galante que dedicou atenção a minha formação no processo de Pós-Graduação na Fundação Antônio Prudente, bem como pela sua oficiosa co-orientação ao projeto de pesquisa. À grande família e amigos pela dedicação e incentivo a minha formação acadêmica. À Fundação Antônio Prudente, Hospital do Câncer e Instituto Ludwig de Pesquisa sobre o Câncer dedico os meus nobres agradecimentos finais. RESUMO Nunes JC. Análise correlacional entre a expressão dos fatores de splicing e a ocorrência de splicing alternativo em tecidos humanos e de camundongos. São Paulo; 2007. [Dissertacão de Mestrado - Fundação Antônio Prudente] Splicing alternativo desempenha uma significante função no aumento da complexidade genômica, produzindo um extenso número de mRNA e isoformas protéicas.
    [Show full text]
  • Strand Breaks for P53 Exon 6 and 8 Among Different Time Course of Folate Depletion Or Repletion in the Rectosigmoid Mucosa
    SUPPLEMENTAL FIGURE COLON p53 EXONIC STRAND BREAKS DURING FOLATE DEPLETION-REPLETION INTERVENTION Supplemental Figure Legend Strand breaks for p53 exon 6 and 8 among different time course of folate depletion or repletion in the rectosigmoid mucosa. The input of DNA was controlled by GAPDH. The data is shown as ΔCt after normalized to GAPDH. The higher ΔCt the more strand breaks. The P value is shown in the figure. SUPPLEMENT S1 Genes that were significantly UPREGULATED after folate intervention (by unadjusted paired t-test), list is sorted by P value Gene Symbol Nucleotide P VALUE Description OLFM4 NM_006418 0.0000 Homo sapiens differentially expressed in hematopoietic lineages (GW112) mRNA. FMR1NB NM_152578 0.0000 Homo sapiens hypothetical protein FLJ25736 (FLJ25736) mRNA. IFI6 NM_002038 0.0001 Homo sapiens interferon alpha-inducible protein (clone IFI-6-16) (G1P3) transcript variant 1 mRNA. Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 GALNTL5 NM_145292 0.0001 (GALNT15) mRNA. STIM2 NM_020860 0.0001 Homo sapiens stromal interaction molecule 2 (STIM2) mRNA. ZNF645 NM_152577 0.0002 Homo sapiens hypothetical protein FLJ25735 (FLJ25735) mRNA. ATP12A NM_001676 0.0002 Homo sapiens ATPase H+/K+ transporting nongastric alpha polypeptide (ATP12A) mRNA. U1SNRNPBP NM_007020 0.0003 Homo sapiens U1-snRNP binding protein homolog (U1SNRNPBP) transcript variant 1 mRNA. RNF125 NM_017831 0.0004 Homo sapiens ring finger protein 125 (RNF125) mRNA. FMNL1 NM_005892 0.0004 Homo sapiens formin-like (FMNL) mRNA. ISG15 NM_005101 0.0005 Homo sapiens interferon alpha-inducible protein (clone IFI-15K) (G1P2) mRNA. SLC6A14 NM_007231 0.0005 Homo sapiens solute carrier family 6 (neurotransmitter transporter) member 14 (SLC6A14) mRNA.
    [Show full text]
  • Análise Correlacional Entre a Expressão Dos Fatores De Splicing E a Ocorrência De Splicing Alternativo Em Tecidos Humanos E De Camundongos
    ANÁLISE CORRELACIONAL ENTRE A EXPRESSÃO DOS FATORES DE SPLICING E A OCORRÊNCIA DE SPLICING ALTERNATIVO EM TECIDOS HUMANOS E DE CAMUNDONGOS JULIO CÉSAR NUNES Dissertação apresentada à Fundação Antônio Prudente para a obtenção do título de Mestre em Ciências Área de Concentração: Oncologia Orientador: Dr. Sandro José de Souza São Paulo 2008 FICHA CATALOGRÁFICA Preparada pela Biblioteca da Fundação Antônio Prudente Nunes, Julio César Análise correlacional entre a expressão dos fatores de splicing e a ocorrência de splicing alternativo em tecidos humanos e de camundongos / Julio César Nunes – São Paulo, 2008. 79p. Dissertação (Mestrado) - Fundação Antônio Prudente. Curso de Pós-Graduação em Ciências - Área de concentração: Oncologia. Orientador: Sandro José Souza Descritores: 1. SPLICING ALTERNATIVO 2. BIOLOGIA MOLECULAR COMPUTACIONAL 3. CÂNCER 4. GENOMICA. AGRADECIMENTOS Agradeço à FAPESP e CAPES pela bolsa de Mestrado. Ao Sandro José de Souza agradeço toda orientação e conhecimento oferecido. Meus especiais agradecimentos ao Pedro Alexandre Favoretto Galante que dedicou atenção a minha formação no processo de Pós-Graduação na Fundação Antônio Prudente, bem como pela sua oficiosa co-orientação ao projeto de pesquisa. À grande família e amigos pela dedicação e incentivo a minha formação acadêmica. À Fundação Antônio Prudente, Hospital do Câncer e Instituto Ludwig de Pesquisa sobre o Câncer dedico os meus nobres agradecimentos finais. RESUMO Nunes JC. Análise correlacional entre a expressão dos fatores de splicing e a ocorrência de splicing alternativo em tecidos humanos e de camundongos. São Paulo; 2007. [Dissertacão de Mestrado - Fundação Antônio Prudente] Splicing alternativo desempenha uma significante função no aumento da complexidade genômica, produzindo um extenso número de mRNA e isoformas protéicas.
    [Show full text]
  • Dissertation
    DISSERTATION submitted to the Combined Faculties for the Natural Sciences and for Mathematics of the Ruperto-Carola University of Heidelberg, Germany for the degree of Doctor of Natural Sciences presented by Syafrizayanti born in Padang, Indonesia Oral examination: March 11, 2014 Production of Personalized Protein Microarrays Optimized production of protein microarrays and the establishment of processes for the representation of protein conformations that occur in individual patients Referees: Prof. Dr. Stefan Wiemann Prof. Dr. Stefan Wölfl Thesis declaration I hereby declare that this thesis has been written only by the undersigned and without any assistance from third parties. Furthermore, I confirm that no sources have been used in the preparation of this thesis other than those indicated in the thesis itself. Heidelberg, 2014 Syafrizayanti Part of this work has been accepted for publication: Syafrizayanti, Betzen C, Hoheisel JD, Kastelic D. Methods for analysing and quantifying protein-protein interactions. Exp. Rev. Prot. (2014) in press. Another manuscript will be submitted while this thesis is evaluated: Syafrizayanti, Lueong SS, Hoheisel JD. Production of personalized protein microarrays (2014). Lueong SS, Syafrizayanti, Hoheisel JD. Production of functional protein microarrays from cDNA products and functional applications (2014). Poster presentations Syafrizayanti, Lueong S, Hoheisel JD, Personalised proteomics by means of individualised protein microarrays, HUPO 12th Annual World Congress, Yokohama, September 2013 Bilen S,
    [Show full text]
  • Copyright by Yen-I Grace Chen 2007
    Copyright by Yen-I Grace Chen 2007 The Dissertation Committee for Yen-I Grace Chen Certifies that this is the approved version of the following dissertation: Proteomic Analysis of the Pre-mRNA Splicing Machinery Utilizing Chromosomal Locus Epitope Tagging in Metazoans Committee: Scott Stevens, Supervisor Henry Bose Robert Krug Arlen Johnson David Hoffman Proteomic Analysis of the Pre-mRNA Splicing Machinery Utilizing Chromosomal Locus Epitope Tagging in Metazoans by Yen-I Grace Chen, M.D. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin August, 2007 Dedication To my loving family Acknowledgements I offer sincere thanks to my advisor, Professor Scott Stevens for providing me the opportunity to join his laboratory. His enthusiasm and patience contributed to the success of my research. I also wish to acknowledge professors Robert Krug, Henry Bose, Arlen Johnson, and David Hoffman for serving as my dissertation committee and for their constructive comments and expertise during my dissertation work; professors Phil Tucker and Karen Artzt for helpful conversations, and William Kuziel for plasmids. I would especially thank Shanna Maika and Deb Surman for their persistence and painstaking work in generating our transgenic mice, breeding, and maintenance; Xin Yao and Chad McKee for technical assistance. I also wish to thank all my colleagues in the Stevens lab: Josh Combs, Adam Roth, Champ Gupton, Rea Lardelli, Jennifer Hennigan and former members Dannialle Clayton and Colin Chu, for helpful discussions and establishing a fun environment for research.
    [Show full text]
  • PDF Download
    Snrp116 Polyclonal Antibody Catalog No : YT4357 Reactivity : Human,Mouse Applications : WB,IHC-p,IF(paraffin section),ELISA Gene Name : EFTUD2 Protein Name : 116 kDa U5 small nuclear ribonucleoprotein component Human Gene Id : 9343 Human Swiss Prot Q15029 No : Mouse Gene Id : 20624 Mouse Swiss Prot O08810 No : Immunogen : The antiserum was produced against synthesized peptide derived from human EFTUD2. AA range:321-370 Specificity : Snrp116 Polyclonal Antibody detects endogenous levels of Snrp116 protein. Formulation : Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. Source : Rabbit Dilution : Western Blot: 1/500 - 1/2000. Immunohistochemistry: 1/100 - 1/300. ELISA: 1/40000. Not yet tested in other applications. Purification : The antibody was affinity-purified from rabbit antiserum by affinity- chromatography using epitope-specific immunogen. Concentration : 1 mg/ml Storage Stability : -20°C/1 year Molecularweight : 109436 1 / 3 Observed Band : 109 Cell Pathway : Spliceosome, Background : elongation factor Tu GTP binding domain containing 2(EFTUD2) Homo sapiens This gene encodes a GTPase which is a component of the spliceosome complex which processes precursor mRNAs to produce mature mRNAs. Mutations in this gene are associated with mandibulofacial dysostosis with microcephaly. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012], Function : function:Component of the U5 snRNP complex required for pre-mRNA splicing.,PTM:Phosphorylated upon DNA damage,
    [Show full text]
  • Microarray Bioinformatics and Its Applications to Clinical Research
    Microarray Bioinformatics and Its Applications to Clinical Research A dissertation presented to the School of Electrical and Information Engineering of the University of Sydney in fulfillment of the requirements for the degree of Doctor of Philosophy i JLI ··_L - -> ...·. ...,. by Ilene Y. Chen Acknowledgment This thesis owes its existence to the mercy, support and inspiration of many people. In the first place, having suffering from adult-onset asthma, interstitial cystitis and cold agglutinin disease, I would like to express my deepest sense of appreciation and gratitude to Professors Hong Yan and David Levy for harbouring me these last three years and providing me a place at the University of Sydney to pursue a very meaningful course of research. I am also indebted to Dr. Craig Jin, who has been a source of enthusiasm and encouragement on my research over many years. In the second place, for contexts concerning biological and medical aspects covered in this thesis, I am very indebted to Dr. Ling-Hong Tseng, Dr. Shian-Sehn Shie, Dr. Wen-Hung Chung and Professor Chyi-Long Lee at Change Gung Memorial Hospital and University of Chang Gung School of Medicine (Taoyuan, Taiwan) as well as Professor Keith Lloyd at University of Alabama School of Medicine (AL, USA). All of them have contributed substantially to this work. In the third place, I would like to thank Mrs. Inge Rogers and Mr. William Ballinger for their helpful comments and suggestions for the writing of my papers and thesis. In the fourth place, I would like to thank my swim coach, Hirota Homma.
    [Show full text]
  • The Tumor Suppressor P53 Provides
    Aus der Klinik für Innere Medizin, Schwerpunkt Hämatologie, Onkologie & Immunologie Direktor: Prof. Dr. Andreas Neubauer des Fachbereichs Medizin der Philipps-Universität Marburg Einfluss der DNA-Bindungskooperativität von p53 auf die Tumorsuppressoraktivität & Beobachtung der Entwicklungsdynamik von Tumorklonen in vitro & in vivo mittels sekretierter Luciferasen Inaugural-Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften dem Fachbereich Medizin der Philipps-Universität Marburg vorgelegt von Joël Pierre Alexandre Charles aus Wiesbaden Marburg, 2015 Angenommen vom Fachbereich Medizin der Philipps-Universität Marburg am: Gedruckt mit Genehmigung des Fachbereichs. Dekan: Herr Prof. Dr. Helmut Schäfer Referent: Herr Prof. Dr. Thorsten Stiewe 1. Korreferent: Frau Prof. Dr. Uta-Maria Bauer Für meine Eltern INHALTSVERZEICHNIS Inhaltsverzeichnis Inhaltsverzeichnis ............................................................................................. I Zusammenfassung .......................................................................................... III Summary ........................................................................................................... V 1. EINLEITUNG .................................................................................................. 1 1.1. Krebs ................................................................................................................. 1 1.2. Tumorentwicklung...........................................................................................
    [Show full text]
  • Chromosomal Breakpoints in Primary Colon Cancer Cluster at Sites of Structural Variants in the Genome
    Research Article Chromosomal Breakpoints in Primary Colon Cancer Cluster at Sites of Structural Variants in the Genome Jordi Camps,1 Marian Grade,1,3 Quang Tri Nguyen,1 Patrick Ho¨rmann,1 Sandra Becker,1 Amanda B. Hummon,1 Virginia Rodriguez,2 Settara Chandrasekharappa,2 Yidong Chen,1 Michael J. Difilippantonio,1 Heinz Becker,3 B. Michael Ghadimi,3 and Thomas Ried1 1Genetics Branch, Center for Cancer Research, National Cancer Institute/NIH; 2Genome Technology Branch, National Human Genome Research Institute/NIH, Bethesda, Maryland; and 3Department of General and Visceral Surgery, University Medicine Go¨ttingen, Go¨ttingen, Germany Abstract 8q, 13, and 20q as well as losses of chromosomes 4q, 8p, 17p, and 18q (2). Genomic aberrations on chromosome 8 are common in colon cancer, and are associated with lymph node and distant Within the last decade, microarray technology has been metastases as well as with disease susceptibility. This extensively applied to survey the cellular transcriptome of common prompted us to generate a high-resolution map of genomic solid tumors, including colorectal cancer, and for colon cancers, imbalances of chromosome 8 in 51 primary colon carcinomas gene expression signatures were subsequently correlated with using a custom-designed genomic array consisting of a tiling clinical outcome (for reviews, see refs. 3–5). However, high- path of BAC clones. This analysis confirmed the dominant role resolution mapping of chromosomal copy number changes has of this chromosome. Unexpectedly, the position of the break- only recently been achieved using BAC or cDNA clone-based arrays points suggested colocalization with structural variants in the (6–10).
    [Show full text]
  • WO 2016/164463 Al 13 October 2016 (13.10.2016) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2016/164463 Al 13 October 2016 (13.10.2016) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C07H 21/04 (2006.01) C12N 15/113 (2010.01) kind of national protection available): AE, AG, AL, AM, C07H 21/00 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (21) Number: International Application DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US20 16/0262 18 HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (22) International Filing Date: KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, 6 April 2016 (06.04.2016) MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (25) Filing Language: English SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (26) Publication Language: English TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 62/144,219 7 April 2015 (07.04.2015) kind of regional protection available): ARIPO (BW, GH, 62/168,528 29 May 2015 (29.05.2015) GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, 62/181,083 17 June 2015 (17.06.2015) TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, (71) Applicant: THE GENERAL HOSPITAL CORPORA¬ DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, TION [US/US]; 55 Fruit Street, Boston, Massachusetts LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, 021 14 (US).
    [Show full text]
  • Dissertation
    DISSERTATION Understanding human mitotic protein complex organisation and phospho-regulation using a combined proteomics and chemical biology approach angestrebter akademischer Grad Doktor der Naturwissenschaften (Dr. rer.nat.) Verfasser: Björn Hegemann Matrikel-Nummer: 0547126 Dissertationsgebiet: A 091 490 (Molekulare Biologie) Betreuer: Dr. Jan-Michael Peters Wien, am 02. Mai 2008 Table of Contents Table of Contents Table of Contents 1 Zusammenfassung 5 Abstract 7 1 Introduction 9 1.1 The cell cycle 9 1.2 Mechanisms of cell cycle control 11 1.3 Sister chromatid cohesion 13 1.4 Protein complexes in mitotic progression 14 1.4.1 How to detect protein complexes? 15 1.5 Mitotic protein kinases 17 1.5.1 How to find mitotic kinases substrates? 18 1.6 Aim of this study 20 2 Results 23 2.1 Manuscript in preparation: Systematic analysis of mitotic protein complexes using tandem affinity purification and mass spectrometry discovers 71 novel potential mitotic protein complexes 24 2.1.1 Abstract 24 2.1.2 Introduction 25 2.1.3 Results 27 2.1.3.1 Bait selection 27 2.1.3.2 Purification and LC-MS/MS analysis 28 2.1.3.3 Complex detection 29 2.1.3.4 Characterisation of novel complexes 33 2.1.3.5 Identification of ANAPC16 as a novel subunit of human APC/C 35 2.1.4 Discussion 38 2.1.5 Materials and methods 41 2.1.5.1 Cell culture and siRNA depletion 41 2.1.5.2 Protein extraction, purification and MS 41 2.1.5.3 Sucrose density gradients 43 2.1.5.4 Ubiquitination assay 43 2.1.5.5 Data processing and clustering analysis 43 2.1.5.6 Antibodies 44 2.1.5.7 Immunofluorescence
    [Show full text]